Versant Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$194K Sell
402
-60
-13% -$15.9K 0.02% 630
2026
Q1
$50.6K Buy
462
+34
+8% +$4.84K 0.01% 1238
2025
Q4
$71.2K Buy
428
+50
+13% +$8.37K 0.01% 910
2025
Q3
$74K Hold
378
0.01% 847
2025
Q2
$34.2K Sell
378
-29
-7% -$2.29K 0.01% 1202
2025
Q1
$24.3K Buy
+407
New +$37.6K ﹤0.01% 1240

Other funds holding ALAB

Versant Capital Management's ALAB Position: Q2 2026 in Review

Versant Capital Management reduced its Astera Labs (ALAB) stake by 13% in Q2 2026, selling an estimated $15.9K and leaving 402 shares worth $194K. The position accounts for 0.02% of the portfolio, ranked #630.

Versant Capital Management first reported a position in ALAB in Q1 2025 and has held it in 6 quarters since. 107 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Versant Capital Management held 402 shares of Astera Labs worth $194K as of Q2 2026.
  • Versant Capital Management sold 60 Astera Labs shares in Q2 2026, an estimated $15.9K.
  • Astera Labs made up 0.02% of Versant Capital Management's portfolio in Q2 2026, its #630 holding.
  • Versant Capital Management first reported a position in Astera Labs in Q1 2025 and has held it in 6 quarters since.
  • 107 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.